Trademark: 98581144
Word
AYRFLUMO
Status
Pending
Status Code
681
Status Date
Wednesday, September 4, 2024
Serial Number
98581144
Mark Type
4
Filing Date
Monday, June 3, 2024
Published for Opposition
Tuesday, October 8, 2024
Trademark Owner History
GlaxoSmithKline Biologicals SA
Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Trademark Events
Jun 3, 2024
New Application Entered
Aug 24, 2024
Assigned To Examiner
Sep 3, 2024
Examiners Amendment -Written
Aug 14, 2024
New Application Office Supplied Data Entered
Aug 14, 2024
Teas Voluntary Amendment Received
Sep 3, 2024
Examiners Amendment E-Mailed
Sep 3, 2024
Examiner's Amendment Entered
Sep 3, 2024
Approved For Pub - Principal Register
Sep 3, 2024
Notification Of Examiners Amendment E-Mailed
CNTNJN
WORKSITE
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov